Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1.
Albini E, Rosini V, Gargaro M, Mondanelli G, Belladonna ML, Pallotta MT, Volpi C, Fallarino F, Macchiarulo A, Antognelli C, Bianchi R, Vacca C, Puccetti P, Grohmann U, Orabona C. Albini E, et al. Among authors: belladonna ml. J Cell Mol Med. 2017 Jan;21(1):165-176. doi: 10.1111/jcmm.12954. Epub 2016 Sep 30. J Cell Mol Med. 2017. PMID: 27696702 Free PMC article.
Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications.
Mandarano M, Bellezza G, Belladonna ML, Van den Eynde BJ, Chiari R, Vannucci J, Mondanelli G, Ludovini V, Ferri I, Bianconi F, Del Sordo R, Cagini L, Albini E, Metro G, Puma F, Sidoni A. Mandarano M, et al. Among authors: belladonna ml. Virchows Arch. 2019 Feb;474(2):159-168. doi: 10.1007/s00428-018-2483-1. Epub 2018 Nov 17. Virchows Arch. 2019. PMID: 30448912
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool.
Mandarano M, Bellezza G, Belladonna ML, Vannucci J, Gili A, Ferri I, Lupi C, Ludovini V, Falabella G, Metro G, Mondanelli G, Chiari R, Cagini L, Stracci F, Roila F, Puma F, Volpi C, Sidoni A. Mandarano M, et al. Among authors: belladonna ml. Front Immunol. 2020 May 27;11:839. doi: 10.3389/fimmu.2020.00839. eCollection 2020. Front Immunol. 2020. PMID: 32536910 Free PMC article.
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients.
Ludovini V, Bianconi F, Siggillino A, Vannucci J, Baglivo S, Berti V, Tofanetti FR, Reda MS, Bellezza G, Mandarano M, Belladonna ML, Metro G, Chiari R, Sidoni A, Puma F, Minotti V, Roila F. Ludovini V, et al. Among authors: belladonna ml. Genes (Basel). 2021 Feb 15;12(2):273. doi: 10.3390/genes12020273. Genes (Basel). 2021. PMID: 33671892 Free PMC article.
Novel mutations in the WFS1 gene are associated with Wolfram syndrome and systemic inflammation.
Panfili E, Mondanelli G, Orabona C, Belladonna ML, Gargaro M, Fallarino F, Orecchini E, Prontera P, Proietti E, Frontino G, Tirelli E, Iacono A, Vacca C, Puccetti P, Grohmann U, Esposito S, Pallotta MT. Panfili E, et al. Among authors: belladonna ml. Hum Mol Genet. 2021 Apr 26;30(3-4):265-276. doi: 10.1093/hmg/ddab040. Hum Mol Genet. 2021. PMID: 33693650 Free PMC article.
Current Challenges for IDO2 as Target in Cancer Immunotherapy.
Mondanelli G, Mandarano M, Belladonna ML, Suvieri C, Pelliccia C, Bellezza G, Sidoni A, Carvalho A, Grohmann U, Volpi C. Mondanelli G, et al. Among authors: belladonna ml. Front Immunol. 2021 Apr 21;12:679953. doi: 10.3389/fimmu.2021.679953. eCollection 2021. Front Immunol. 2021. PMID: 33968089 Free PMC article. Review.
86 results